In this week's Homerun Slides, talking to patients about SGLT-2 as a treatment option.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #62: Mechanisms of Insulin Signal Transduction Part 6 of 8
The glucose transport effector system, GLUT4 vesicle translocation and trafficking: Glucose transport proteins are the key functional units of the glucose transport effector system. Multiple glucose transporter genes have been identified that encode a family of homologous proteins exhibiting different functional properties and marked differences in tissue-specific expression.
Read More »CGM Will Change The Way We Treat Type 1 And Type 2 Diabetes
Let’s start off with what is in the pipeline.
Read More »Starting Insulin Earlier Can Limit Weight Gain for Type 2 Diabetes
Early initiation of therapy hoped to reduce long-term morbidity, mortality by getting to goal earlier; potentially alter the natural history of the disease.
Read More »Pancreatic Cancer Sign: Rapid Deterioration of Diabetes Control
At diagnosis and shortly thereafter, if their control deteriorates rapidly it could be a sign of asymptomatic pancreatic cancer.
Read More »New Hypertension Guidelines for Adults Age 60 and Older
Blood pressure recommendations have been swinging back and forth for a number of decades.
Read More »Once Again, Periodontitis Tied to Diabetes Complications
Adults with type 2 diabetes and microvascular complications have an increased risk for severe periodontitis compared with those without microvascular complications.
Read More »Is Enteric Coated Aspirin Effective For Prevention of Strokes and Heart Attacks?
Commonly recommended aspirin is given to prevent irritation to the stomach.
Read More »Pre-Dental Surgery A1C Test
Do you think dentists should do A1c tests for patients with periodontal disease, especially before surgery, then report the results to their patient's primary care doctor? Follow the link to share your opinion!
Read More »Question 872
The United Kingdom Prospective Diabetes Study early results data suggested metformin conferred greater cardiovascular benefits to the overweight diabetes participants than dietary interventions alone. All of the following were observed for the metformin group EXCEPT: A. A relative risk reduction for myocardial infarction of 39%. B. A relative risk reduction for all-cause mortality of 36%. C. A relative risk reduction for diabetes related death of 42%. D. An overall mean A1c reduction of 1.5%. Did you get it right? Follow the link to find out!
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.